Quinn Pharmaceuticals
4 drugs in NADAC|4 Generic,0 Brand
Quinn Pharmaceuticals lists 4 NDCs in the CMS NADAC file (4 generic, 0 brand), at an average NADAC of $0.16 per unit, with a week-over-week move of -0.9% across products that moved. The firm's full portfolio, pricing trend are listed below.
Total Drugs
4
4G / 0B
Avg Price / Unit
$0.1598
$0.10 – $0.29
Avg 7d Change
-0.89%
Across 4 drugs with changes
7d Activity
of 4 total drugs
Portfolio Price Trend
Monthly average NADAC price across all drugs
Keep following this manufacturer
These next-step links connect the manufacturer page to the markets, classes, and trend views most likely to deepen research.
Lead market
GLYCOPYRROLATE market
See the molecule this manufacturer shows up in most often and compare it against competing suppliers.
Lead class
Anticholinergic therapeutic class
Review the broader class where Quinn Pharmaceuticals has the strongest current portfolio footprint.
Trend hub
Portfolio trend view
Jump to the trend hub to compare this manufacturer against the rest of the market on weekly price movement.
Guide
NADAC pricing primer
Use the explainer for context on the benchmark this manufacturer is being compared against.
Frequently Asked Questions
How many drugs does Quinn Pharmaceuticals make?
Quinn Pharmaceuticals lists 4 NDCs in the CMS NADAC file — 4 generic and 0 brand products.
What is the average price of Quinn Pharmaceuticals drugs?
The average NADAC across Quinn Pharmaceuticals's portfolio is $0.1598 per unit, ranging from $0.0977 to $0.2938.
What types of drugs does Quinn Pharmaceuticals make?
Quinn Pharmaceuticals makes drugs across 6 FDA pharmacologic classes. The most common by NDC count are Anticholinergic (2), Hepatitis B Virus Nucleoside Analog Reverse Transcriptase Inhibitor (1), Human Immunodeficiency Virus Nucleoside Analog Reverse Transcriptase Inhibitor (1), Herpes Simplex Virus Nucleoside Analog DNA Polymerase Inhibitor (1), Herpes Zoster Virus Nucleoside Analog DNA Polymerase Inhibitor (1).
Has Quinn Pharmaceuticals had any drug recalls?
No FDA enforcement recalls are matched to Quinn Pharmaceuticals in the openFDA feed.
How has Quinn Pharmaceuticals's pricing changed recently?
Over the past 7 days, 3 Quinn Pharmaceuticals products rose and 1 fell, with a portfolio-wide average change of -0.9%.
| Drug ↕ | Price | 7d Change ↕ |
|---|---|---|
TENOFOVIR DISOPROXIL FUMARATE 300 MG TABLET Tenofovir Disoproxil Fumarate | $0.2938 per EA | -5.53% |
GLYCOPYRROLATE 2 MG TABLET GLYCOPYRROLATE | $0.1481 per EA | +0.63% |
GLYCOPYRROLATE 1 MG TABLET GLYCOPYRROLATE | $0.0997 per EA | +0.93% |
ACYCLOVIR 200 MG CAPSULE Acyclovir | $0.0977 per EA | +0.41% |